Market Tracker

02/23 5:15pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.16
Delayed Data
As of Feb 23
 +0.09 / +1.48%
Today’s Change
4.60
Today|||52-Week Range
11.72
+3.53%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close6.07
Today’s open6.09
Day’s range5.98 - 6.18
Volume955,607
Average volume (3 months)1,086,602
Market cap$432.9M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-704.00%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+700.24%
P/E ratioNM
Price/Sales8.73
Price/Book4.13

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...-1.39-5.07%
ASMBAssembly Biosciences...+0.80+1.43%
CARACara Therapeutics In...+0.46+3.32%
KPTIKaryopharm Therapeut...+0.26+1.78%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$69.4M
Annual profit (last year)$10.8M
Net profit margin15.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
CFO, Principal Accounting Officer &
Senior VP
Patrick Fabbio
Corporate headquarters
New York, New York

Forecasts